相关实验视频
Updated: Jan 16, 2026
08:40
Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
7.5K
心血管并发症在炎症性肠病中增加:实现个性化风险估计的途径
Vito Annese1,2, Maria Laura Annunziata1, Guglielmo Albertini Petroni1
1Unit of Gastroenterology, I.R.C.C.S. San Donato Policlinic, San Donato Milanese, 20097 Milan, Italy.
Journal of personalized medicine
|September 26, 2025
概括
这项研究调查了炎症性肠病 (IBD) 中心血管疾病 (CVD) 风险. 研究人员的目标是开发IBD特异性风险评分,以改善心血管疾病预测,特别是在年轻人中.
科学领域:
- 心脏病学 心脏病学
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
背景情况:
- 在全球范围内,炎症性肠病 (IBD) 正在增加,50%的患者经历了肠外表现.
- 心血管疾病 (CVD) 是IBD患者死亡的主要原因.
- 在IBD中,慢性炎症和免疫失调可能会增加心血管疾病的风险,尽管传统的风险因素较少.
研究的目的:
- 为了澄清患有炎症性肠道疾病 (IBD) 的患者的心血管风险概况.
- 为现有的心血管风险得分开发IBD特定的校正因子.
- 改善IBD患者的心血管疾病风险分层,特别是40岁以下的患者.
主要方法:
- 预期招募IBD患者队列进行全面的CV风险因素,生活方式和疾病特征评估.
- 在2年内追踪主要不良心血管事件 (MACE),与匹配的非IBD队列进行对比.
- 多组学分析 (基因组,蛋白质组,转录组,微生物组) 和人工智能框架用于MACE案例中复杂数据分析.
主要成果:
- 到目前为止,已注册了150多名IBD患者.
- 目前正在收集详细的表型数据和生物样本.
- 该研究正在积极收集关于MACE发病率和风险因素的数据.
结论:
- 这项研究旨在确定IBD特异性心血管疾病风险评分.
- 这种新的得分将提高IBD患者的风险评估,特别是年轻人.
- 改善风险分层可以导致更早的干预和IBD中更好的心血管结果.
相关概念视频
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
903
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
903
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
643
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
643
01:30Inflammatory Bowel Disease II: Crohn's Disease
960
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
960
01:29Inflammatory Bowel Disease IV: Pharmacological Management
521
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
521
01:17Chronic Bowel Disorders: Introduction
747
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
747
01:21Inflammatory Bowel Disease V: Surgical Management
451
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
451